{{Rsnum
|rsid=4809324
|Gene=RTEL1
|Chromosome=20
|position=63686867
|Orientation=plus
|GMAF=0.1125
|Gene_s=PLEKHJ1,RTEL1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 15.9 | 83.2
| HCB | 0.7 | 21.9 | 77.4
| JPT | 2.7 | 26.5 | 70.8
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 5.3 | 94.7
| CHB | 0.7 | 21.9 | 77.4
| CHD | 1.9 | 16.7 | 81.5
| GIH | 1.0 | 10.9 | 88.1
| LWK | 0.0 | 0.9 | 99.1
| MEX | 13.8 | 39.7 | 46.6
| MKK | 0.0 | 7.1 | 92.9
| TSI | 1.0 | 13.7 | 85.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19578366
|Trait=Glioma (high-grade)
|Title=Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
|RiskAllele=C
|Pval=2E-9
|OR=1.60
|ORtxt=[1.37-1.87]
|OA=1
}}

{{omim
|id=613031
|rsnum=4809324
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs4809324
|overall_frequency_n=17
|overall_frequency_d=128
|overall_frequency=0.132812
|n_genomes=11
|n_genomes_annotated=0
|n_haplomes=14
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}